Articles

The Promise and Challenge of Big Data for Pharma

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing.

Source: hbr.org
Author: Ryan Copping and Michael Li

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s